1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Drug Delivery Technologies Market Forecast 2015-2025: Prospects for Leading Companies

Report Details
Drug Delivery Technology – assess products, developments, and revenue prospects
What does the future hold for the drug delivery technologies market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects.

Our 204 page report provides 113 tables, charts, and graphs covering 6 leading and distinct submarkets. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions. Increasing development and use of biological drugs (biologics) will increase worldwide sales of drug delivery technologies from 2015 to 2025, our study shows.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. You will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of 5 exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Dr Igor Gonda, President and CEO & David Cipolla, Senior Director of Pharmaceutical Sciences, Aradigm
- Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
- Dr. Bridget Martell, Chief Medical Officer and Vice President of Clinical Product Development, Juniper Pharmaceuticals
- John McCarter, Director of Business Development, Soluble Therapeutics
- Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark

You will find prospects for key submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of 6 major submarkets to 2025:
- Oral Drug Delivery Market Forecast 2015-2025
- Inhalable Drug Delivery Market Forecast 2015-2025
- Injectable/Implantable Drug Delivery Market Forecast 2015-2025
- Transdermal Drug Delivery Market Forecast 2015-2025
- Ocular Drug Delivery Market Forecast 2015-2025
- Nasal/Buccal Drug Delivery Market Forecast 2015-2025

Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.

How will those drug delivery markets expand? Which applications will generate the most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects in the leading regions and countries?
In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets:
- US
- Japan
- Germany
- France
- UK
- Spain
- Italy
- China
- India
- Brazil
- Russia
- South Korea
- Mexico
- Rest of the World

Many opportunities exist within the drug delivery technologies market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints.

Leading companies and potential for market growth
Overall world revenue for the drug delivery technologies market will reach $159.3bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies and others, including:
- Alkermes
- 3M
- Skyepharma
- BD
- Antares Pharma
- pSivida
- Applied Pharma Research
- Ethypharm
- Glycologic
- NanoPass Technologies

In general, a company profile gives y

Table Of Contents

Drug Delivery Technologies Market Forecast 2015-2025: Prospects for Leading Companies
Table of Contents
1. Report Overview
1.1 Global Drug Delivery Technology Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Drug Delivery Technology Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain

2. Introduction to Drug Delivery Technology
2.1 Drug Delivery Technologies (DDT)
2.1.1 Oral Drug Delivery: Enter Through the Mouth
2.1.2 Pulmonary Delivery: Delivered by Inhalation
2.1.3 Injection as a Route of Drug Delivery
2.1.4 Transdermal Delivery: More Patient-Friendly
2.1.5 Various Transmucosal Delivery Routes for Delivery
2.1.6 Ocular Delivery: Overcoming Unique Barriers
2.2 Sustained/Controlled Release Systems
2.3 Biopharmaceuticals
2.3.1 An introduction to the Biological Drugs Market
2.3.2 Biologics: A Rising Drugs Market
2.3.3 Biotech Drugs with Associated Drug Delivery Technologies
2.3.4 Pegylated Interferons
2.3.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.3.6 The Main Challenges Facing Biological Drug Delivery
2.4 Market Definition

3. Drug Delivery Technology: World Market 2015-2025
3.1 The Global Drug Delivery Technology Market: Overview
3.2 The Global Drug Delivery Technologies Market in 2014
3.3 The Global Drug Delivery Technology Market Forecast 2015-2025
3.4 How Will Segmental Market Shares Change to 2025?
3.5 Biologics: A Driver for Growth in Drug Delivery Technologies
3.5.1 The Global Biological Drugs Market Forecast
3.5.2 Leading Classes of Biological Drugs
3.5.3 Monoclonal Antibodies: Largest Sector in Biologics
3.5.4 Human insulin: Leading the Therapeutic Protein Segment
3.5.5 Interferon Products for the Treatment of Hepatitis
3.6 Vaccines: Meeting the Unmet Needs
3.6.1 The Global Vaccines Market Forecast
3.7 Drug Delivery Technology: Drivers and Restraints 2015-2025

4. Drug Delivery Technologies Submarkets 2015-2025
4.1 Oral Drug Delivery Technology
4.1.1 Oral Drug Delivery Technology Market Forecast 2015-2025
4.1.2 Trends and Developments
4.1.2.1 Delivering APIs to the Colon
4.1.2.2 Google Investing on Robotic Pill
4.1.2.3 Better Tools to Model Drug Absorption
4.1.3 Oral Drug Delivery Technologies: Drivers and Restraints 2015-2025
4.2 Inhalable Drug Delivery Technology
4.2.1 Inhalable Drug Delivery Technology Market Forecast 2015-2025
4.2.2 Trends and Developments
4.2.2.1 Inhalable Liposomal Antibiotics to Penetrate Biofilms
4.2.2.2 Condensation Aerosol Generated by Heat
4.2.2.3 Inhaled Insulin: Will It Succeed This Time?
4.2.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2015-2025
4.3 Injectable/Implantable Delivery Technology
4.3.1 Injectable/Implantable Delivery Technology Market Forecast 2015-2025
4.3.2 Trends and Developments
4.3.2.1 Ultrasound Activated Targeted Drug Delivery
4.3.2.2 Intradermal Vaccine Delivery
4.3.2.3 First Flu Vaccine Jet Injector Approved in the US
4.3.3 Injectable/Implantable Delivery Technologies: Drivers and Restraints 2015-2025
4.4 Transdermal Drug Delivery Technology
4.4.1 Transdermal Drug Delivery Technology Market Forecast 2015-2025
4.4.2 Trends and Developments
4.4.2.1 Iontophoretic Transdermal Patch for Migraine Approved in the US
4.4.2.2 Microneedle Patch for Vaccine Delivery
4.4.2.3 Ultrasonic Waveforms to Enlarge Skin Pores
4.5 Ocular Drug Delivery Technology
4.5.1 Ocular Drug Delivery Technology Market Forecast 2015-2025
4.5.2 Trends and Developments
4.5.2.1 Non-Surgical Microinjection to Retina and Choroid to be used for Gene Therapy
4.6 Nasal/Buccal Drug Delivery Technology
4.6.1 Nasal/Buccal Drug Delivery Technology Market Forecast 2015-2025
4.6.2 Trends and Developments
4.6.2.1 Nasal Spray with Live Attenuated Influenza Vaccine
4.6.2.2 Mucosal Vaccine Delivered through Nose or Mouth
4.6.2.3 Buccal Insulin Spray in Clinical Trials

5. Leading National Markets 2015-2025
5.1 World Drug Delivery Technology Market: Regional Forecast 2015-2025
5.1.1 How Will Regional Market Shares Change to 2025?
5.2 US Drug Delivery Technology Market 2015-2025
5.2.1 US Drug Delivery Technology Market Forecast 2015-2025
5.2.2 FDA Guideline for Combination Products
5.2.3 Eli Lilly to Establish Drug Delivery Centre
5.3 EU5 Drug Delivery Technology Market 2015-2025
5.3.1 EU5 Drug Delivery Technology Market Forecast 2015-2025
5.3.2 How Will the European National Market Shares Change to 2025?
5.3.3 The German Drug Delivery Technology Market Forecast 2015-2025
5.3.4 The French Drug Delivery Technology Market Forecast 2015-2025
5.3.5 The UK Drug Delivery Technology Market Forecast 2015-2025
5.3.6 The Spanish Drug Delivery Technology Market Forecast 2015-2025
5.3.7 The Italian Drug Delivery Technology Market Forecast 2015-2025
5.4 Japanese Drug Delivery Technology Market 2015-2025
5.4.1 Japanese Drug Delivery Technology Market Forecast 2015-2025
5.4.2 The New Sakigake Designation System May Accelerate Innovative Drug Development
5.5 Chinese Drug Delivery Technology Market 2015-2025
5.5.1 Chinese Drug Delivery Technology Market Forecast 2015-2025
5.6 Indian Drug Delivery Technology Market 2015-2025
5.6.1 Indian Drug Delivery Technology Market Forecast 2015-2025
5.7 Brazilian Drug Delivery Technology Market 2015-2025
5.7.1 Brazilian Drug Delivery Technology Market Forecast 2015-2025
5.8 Russian Drug Delivery Technology Market 2015-2025
5.8.1 Russian Drug Delivery Technology Market Forecast 2015-2025
5.9 South Korean Drug Delivery Technology Market 2015-2025
5.9.1 South Korean Drug Delivery Technology Market Forecast 2015-2025
5.10 Mexican Drug Delivery Technology Market 2015-2025
5.10.1 Mexican Drug Delivery Technology Market Forecast 2015-2025
5.11 Rest of the World Drug Delivery Technology Market 2015-2025
5.11.1 Rest of the World Drug Delivery Technology Market Forecast 2015-2025

6. Leading Companies in the Drug Delivery Technology Market 2015
6.1 Alkermes: Focused on Extended and Controlled Release
6.1.1 Alkermes: Drug Delivery Technology Portfolio
6.1.1.1 Long-Acting Injectables
6.1.1.2 Oral Controlled Release
6.1.1.3 Nanoparticle
6.1.1.4 Other Technologies
6.1.2 Alkermes: Product Portfolio
6.1.3 Alkermes: Pipeline Products 2015
6.1.4 Alkermes: Future Outlook
6.1.5 Manufacturing Facility in Georgia Sold to Recro Pharma
6.2 3M: 50 Years of Drug Delivery Technology Development
6.2.1 3M: Drug Delivery Technology Portfolio
6.2.1.1 Oral and Topical Drug Delivery
6.2.1.2 MDI for Nasal and Inhalable Drugs
6.2.1.3 Transdermal patch Technology
6.2.1.4 Microneedle Technology
6.2.2 3M: Future Outlook
6.3 Skyepharma: Solutions for Inhalable, Oral, Topical and Injectable Drugs
6.3.1 Skyepharma: Drug Delivery Technology Portfolio
6.3.1.1 Inhalation Drug Delivery Technology
6.3.1.2 Oral Drug Delivery Technology
6.3.1.3 Injectable Drug Delivery Technology
6.3.1.4 Topical Drug Delivery Technology
6.3.2 Skyepharma: Pipeline Products 2015
6.3.3 Skyepharma: Future Outlook
6.4 BD: A History of Hypodermic Needles and Syringes
6.4.1 BD: Drug Delivery Technology Portfolio
6.4.1.1 Prefillable Syringe Systems
6.4.1.2 Self-Injection Systems
6.4.1.3 Pen Needles
6.4.1.4 Safety and Shielding Systems
6.4.2 BD: Future Outlook
6.4.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
6.4.4 BD Acquired Injection Safety Firms
6.5 Antares Pharma: Leading the Needle-Free Injector Market
6.5.1 Antares Pharma: Drug Delivery Product Portfolio
6.5.2 Antares Pharma: Future Outlook
6.5.3 Antares Pharma: Products in Development
6.6 pSivida: Targeting the Back of the Eye
6.6.1 pSivida: Drug Delivery Technology Portfolio
6.6.1.1 Durasert Technology
6.6.1.2 Tethadur Technology
6.6.2 pSivida: Pipeline Products 2015
6.6.3 psidiva: Collaborations
6.6.4 pSivida: Future Outlook
6.6.5 New Funded Technology Evaluation Agreements
6.7 Applied Pharma Research (APR)
6.7.1 APR's Technology and Product Offerings
6.8 Ethypharm
6.8.1 Ethypharm's Currently Marketed Products
6.9 Glycologic
6.9.1 Glycologic's Drug Delivery Technologies
6.9.2 Glycologic's Pipeline Developments
6.10 Nanopass Technologies
6.10.1 Nanopass Drug Delivery Products
6.10.1.1 Anti-aging Microdermabrasion
6.10.1.2 Micronjet Needle

7. Qualitative Analysis of the Drug Delivery Technology Market 2015-2025
7.1 SWOT Analysis of the Drug Delivery Technology Market
7.2 Strengths
7.2.1 Increasing Competition and Patent Expiry in the Biologics Market
7.2.2 The Rise of Biosimilars
7.2.3 Increasing Global Diabetes Population
7.3 Weaknesses
7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
7.3.2 Companies Need to Develop a More Liberal Mindset
7.4 Opportunities
7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
7.4.2 Possible New Delivery Methods for Insulin
7.5 Threats
7.5.1 Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
7.5.2 Cost effective Solutions May not be Available

8. Research Interviews
8.1 Dr Igor Gonda, President and CEO and David Cipolla, Senior Director of Pharmaceutical Sciences, Aradigm
8.1.1 Aradigm and the AERx Pulmonary Drug Delivery Platform
8.1.2 The Need for Innovative Pulmonary Delivery Technologies
8.1.3 On the Competitive Landscape for the Pulmonary Drug Delivery Technology
8.1.4 Asthma and COPD Lead, Serious Lung Infections to Catch Up
8.1.5 On Global Reach and Licensing Opportunities
8.2 Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
8.2.1 The Need for Novel Delivery Mechanisms Driving Growth
8.2.2 Therapeutic Areas That Are Propelling Drug Delivery Technologies
8.2.3 Drug Delivery Barriers and the Need for Targeting
8.2.4 Advancements in Drug Delivery in the Coming Years
8.2.5 Future Challenges for Drug Delivery Technologies
8.2.6 Future Opportunities for Drug Delivery Technologies
8.3 Dr. Bridget Martell, Chief Medical Officer and Vice President of Clinical Product Development, Juniper Pharmaceuticals
8.3.1 Focused on Women's Health and Drug Delivery
8.3.2 On Competitive Landscape for Vaginally-Administered Products
8.3.3 Unique Segmented IVR Technology
8.3.4 Therapeutic Areas of BDS and IVR Technologies
8.3.5 Pipeline Candidate Addressing Unmet Needs
8.3.6 On Trends and Developments of the Market
8.4 John McCarter, Director of Business Development, Soluble Therapeutics
8.4.1 Focused on Biologics Formulation Screening Technology
8.4.2 On Trends and Developments in the Market
8.4.3 The HSC Technology is Faster and Cheaper with Lower Protein Consumption
8.4.4 Patient Convenience is the Key
8.4.5 On Important Therapeutic Areas
8.5 Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
8.5.1 On the Current State of Drug Delivery Technologies
8.5.2 The ‘Magic Bullet' - A Challenge for Innovation
8.5.3 Self-Assembling Protein Systems and the Use of Nanostructures for Drug Targeting
8.5.4 Technological Developments in Drug Development - Quantum Dots, Silicon Structures, and Polymeric Materials
8.5.5 On Future Challenges and Opportunities

9. Conclusions
9.1 The World Drug Delivery Technology Market in 2014
9.1.1 Current Leading Drug Delivery Technology Segments
9.1.2 Notable Drug Delivery Technology Companies
9.1.3 Leading Regional Markets
9.2 World Drug Delivery Technology Market Forecast 2015-2025
9.3 The Future of the Drug Delivery Technology Market
9.3.1 Transdermal and Injectable Drug Delivery Technologies Set For High Growth
9.3.2 Biologics and Biosimilars to Drive Market Growth

10. Glossary

List of Tables
Table 1.1 Leading National Drug Delivery Technology Market Forecast 2015-2025 ($bn, AGR%, CAGR%)
Table 2.1 Top 8 Biotech Drugs by Sales ($bn), 2014
Table 2.2 Top 8 Companies by Biologic Sales ($bn), 2014
Table 3.1 The Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 3.2 Global Biological Drugs Market: Revenues ($bn), AGR (%), CAGR (%), 2012-2023
Table 3.3 Global Vaccines Market: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.1 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.2 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.3 Insulin Inhalers Withdrawal from the Market or Pipeline, 2015
Table 4.4 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.5 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.6 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.7 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.1 World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Region, 2014-2025
Table 5.2 US Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.3 EU5 Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.4 German Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.5 French Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.6 UK Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.7 Spanish Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.8 Italian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.9 Japanese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.10 Chinese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.11 Indian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.12 Brazilian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.13 Russian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.14 South Korean Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.15 Mexican Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.16 Rest of the World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
Table 6.1 Leading Companies: Areas of Interest by Type of Delivery
Table 6.2 Alkermes: Overview, 2015
Table 6.3 Alkermes: Drug Delivery Technology Portfolio and Pipeline 2015
Table 6.4 Products Utilising Alkermes' Drug Delivery Technology (Indication, Partner and Territory) 2015
Table 6.5 Alkermes: Pipeline Products (Product Candidate, Target Indication, Status), 2015
Table 6.6 Alkermes: Revenue ($m), AGR (%), CAGR (%), 2010-2014
Table 6.7 Alkermes: Revenue ($m) by Business Segment, 2010-2014
Table 6.8 3M: Overview, 2015
Table 6.9 3M: Health Care Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 6.10 Skyepharma: Overview, 2015
Table 6.11 Skyepharma: Inhalation Drug Formulation Technology Portfolio 2015
Table 6.12 Products Utilising Skyepharma's Inhalation Drug Delivery Technology (Product Name, Indication, Licensee, Description), 2015
Table 6.13 Skyepharma: Oral Drug Formulation Technology Portfolio (Technology, Description, Product name) 2015
Table 6.14 Products Utilising Skyepharma's Oral Drug Delivery Technology (Product name, Indication, Licensee, Description), 2015
Table 6.15 Skyepharma: Pipeline Products 2015 (Product name, Formulation, Indication, Status, Partner Name)
Table 6.16 Skyepharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014
Table 6.17 Skyepharma: Revenue ($m) by Income Stream, 2010-2014
Table 6.18 BD: Overview, 2015
Table 6.19 BD: Drug Delivery Products by Segment, 2015
Table 6.20 BD: Revenue ($bn) by Geographic Region, 2012-2014
Table 6.21 BD Medical: Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 6.22 Antares Pharma: Overview, 2015
Table 6.23 Antares Pharma: Product Portfolio 2015 (Product, Drug, Partner, Indication, Territory)
Table 6.24 Antares' Revenue ($m) from Major Customers, 2010-2014
Table 6.25 Antares Pharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014
Table 6.26 Antares Pharma: Products in Development 2015 (Product Name, Drug, Partner, Indication, Territory, Status)
Table 6.27 pSivida: Overview, 2015
Table 6.28 Products Utilising Durasert Technology 2015 (Product, Indication, Status, Partner)
Table 6.29 pSivida: Revenue ($m) by Income Stream, 2011-2014
Table 6.30 Selected Ethypharm's Pain Relieving Products, 2015
Table 7.1 SWOT Analysis of the Drug Delivery Technology Market, 2015-2025

List of Figures
Figure 1.1 South Korea Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 1.2 Global Drug Delivery Technology Market Segmentation Overview 2015
Figure 3.1 The Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 3.2 Market Shares (%) of Leading Drug Delivery Market Segments, 2014
Figure 3.3 Market Shares (%) of Leading Drug Delivery Market Segments, 2019
Figure 3.4 Market Shares (%) of Leading Drug Delivery Market Segments, 2025
Figure 3.5 Global Biological Drugs Market: Revenues ($bn), AGR (%), 2012-2023
Figure 3.6 Global Vaccines Market: Revenues ($bn), AGR (%), 2014-2025
Figure 3.7 Drug Delivery Technologies: Market Drivers and Restraints 2015-2025
Figure 4.1 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 4.2 Oral Drug Delivery Technologies: Drivers and Restraints 2015-2025
Figure 4.3 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 4.4 Inhalable Drug Delivery Technologies: Drivers and Restraints 2015-2025
Figure 4.5 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 4.6 Injectable/Implantable Drug Delivery Technologies: Drivers and Restraints 2015-2025
Figure 4.7 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 4.8 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 4.9 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
Figure 5.1 World Drug Delivery Technology Market: Revenues ($bn) by Region, 2014
Figure 5.2 World Drug Delivery Technology Market: Revenues ($bn) by Region, 2014-2025
Figure 5.3 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2014
Figure 5.4 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2019
Figure 5.5 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2025
Figure 5.6 US Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.7 EU5 Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.8 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2014
Figure 5.9 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2019
Figure 5.10 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2025
Figure 5.11 German Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.12 French Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.13 UK Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.14 Spanish Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.15 Italian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.16 Japanese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.17 Chinese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.18 Indian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.19 Brazilian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.20 Russian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.21 South Korean Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.22 Mexican Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 5.23 Rest of the World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
Figure 6.1 Alkermes: Revenue ($m), AGR (%), 2010-2014
Figure 6.2 Alkermes: Revenue ($m) by Type, 2010-2014
Figure 6.3 Alkermes: Manufacturing and royalty revenue ($m) by Product, 2010-2014
Figure 6.4 Alkermes: Revenue ($m) by Main Customers 2014
Figure 6.5 3M: Health Care Revenue ($m), AGR (%), 2009-2014
Figure 6.6 Skyepharma: Revenue ($m), AGR (%), 2010-2014
Figure 6.7 Skyepharma: Revenue ($m) by Income Stream, 2010-2014
Figure 6.8 BD: Revenue ($bn) by Geographic Region, 2012-2014
Figure 6.9 BD Medical: Revenue ($m), AGR (%), 2009-2014
Figure 6.10 Antares' Revenue from Major Customers, 2010-2014
Figure 6.11 Antares Pharma: Revenue ($m), AGR (%), 2010-2014
Figure 6.12 pSivida: Revenue ($m) by Income Stream, 2011-2014

Companies Listed
3M
Acorda
Actavis
Adamis
Aleza Pharmaceuticals
Alkermes
Almirall
Alza
Antares Pharma
Applied Pharma Research
Aradigm
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals
BD
Biogen
BioGeneration Ventures
Bioject Medical Technologies
Boehringer Ingelheim
Bristol¬Myers Squibb
CareFusion Corporation
Cephalon
Changchun BCHT
Chiesi
Cilag
Cima Labs
Clearside
Cosmo Pharmaceuticals
CRISI Medical Systems
CTCBIO
Daiichi
Elan Drug Technologies
Elcam Medical
Eli Lilly
Ethypharm
Ferring
Flamel
Genentech
GlaxoSmithKline
Glycologic
Google
GSK
Haselmeir
Horizon Pharma
ImmusanT
Innovent Biologics
Insmed
Invion
iScience Interventional Corporation
JandJ
Janssen
JCR Pharmaceuticals
Kyorin
MannKind
Meda Pharmaceuticals
Medac
Medimetrics
MedImmune
MedSciences Capital
Merck Serono
Mucosis
Mundipharma
Nanopass Technologies
Nektar Therapeutics
Nexvax2
NHTherapeutics
Novartis
Novo Nordisk
NuPathe
NV NOM
OwenMumford
Pacira Pharmaceuticals
Pari Pharma
Permatec
Pfizer
PharmaJet
Presspart
ProStrakan
pSivida
Pulmagen
Ranbaxy
Rani Therapeutics
Recro Pharma
Regeneron Pharmaceuticals
Roche
Sandoz
Sanofi-Aventis
Santen
Shionogi
SHL Group
Shreya Life Sciences
Skyepharma
Smoofi
Spark Therapeutics
STADA Arzneimittel
Takeda
Teva
UU Holdings
Vetter Pharma
West Pharmaceuticals
Ypsomed

Other Organisations Mentioned in This Report
Emory University School of Medicine
Georgia Institute of Technology
Hospital for Special Surgery
University of Oxford

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs ...

BRIC Insulin Delivery Market Outlook to 2022

BRIC Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by Global Data

BRIC Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Insulin Delivery Market Outlook to 2022", provides key market data on the BRIC Insulin Delivery market. The report ...

Asia-Pacific Insulin Delivery Market Outlook to 2022

Asia-Pacific Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by Global Data

Asia-Pacific Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "Asia-Pacific Insulin Delivery Market Outlook to 2022", provides key market data on the Asia-Pacific Insulin Delivery ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.